U.S. federal trademark · Serial No. 87579575
Research and development of pharmaceuticals for the treatment of cancer and immune system-related diseases and disorders; clinical research in the field of cancer treatment and treatment of disorders related to the immune system; medical research services in the field of cancer, namely, priming and stimulating T cells and Natural Killer cells for research purposes
Medical treatment services, namely, administration of gene therapy; medical and therapeutic services, namely, immunotherapy services comprising harvesting, transducing, or otherwise manipulating ex-vivo and re-administering blood cells
Scientific apparatus for priming and stimulating particular cells of the immune system for the treatment of cancer and autoimmune diseases and disorders
Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of cancer and tumors via tumor antigen reactive T cells and Natural Killer cells; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceuticals for use in the treatment of infectious diseases and in cellular transplants; pharmaceutical preparations for immunotherapy, including T cell and Natural Killer cell therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.